Over the last few months, our program, track, and session chairs have actively worked with us to create a timely, relevant, and inclusive conference program that tackles the various aspects of precision medicine and covers:
• Diagnostic and therapeutic breakthroughs
• How AI and machine learning are reshaping the future of healthcare
• The latest discoveries on the impact of the microbiome on human health
• How we can ensure that patient care is at the center of it all
• Current population studies demonstrating the value of genomics on clinical decision making
• Regulatory and reimbursement hurdles that we still need to overcome
• Recent technological advancements that contribute to value-based healthcare.

Here we share some PMWC 2020 Silicon Valley program committee key insights along with an invitation to everyone to work as a team to advance precision medicine and make it accessible to everyone:

Mike Pellini, M.D., M.B.A, Managing Partner of Section 32, Chairman of Foundation Medicine. PMWC 2020 Silicon Valley Program Chair
“When we can bring together the best of the drug and diagnostic development world with the best and the brightest in the machine learning/AI world, then we truly work together as a team.”

Theresa LaVallee, Ph.D., Vice President, Translational Medicine and Regulatory Affairs, Parker Institute for Cancer Immunotherapy. PMWC 2020 Track 1 Emerging Therapeutics Chair
“There are lots of ways immunotherapy is disrupting the way that we approach cancer treatment.”

“I believe, you have to look at the total cost of care and then the survival benefit that is afforded. Only that way can we really figure out the economics of it.”

Stan Huff, M.D., Chief Medical Informatics Officer, Intermountain Healthcare. PMWC 2020 Track 2 AI & Data Sciences Chair
“The call is to invest the time to create interoperability so that we can take better care of patients.”

“New technologies such as digital health, AI/ML, and Data Sciences will help us discover new knowledge.”

“The single biggest motivation to create FHIR (Fast Healthcare Interoperability Resources) is to make sharing standard data easier.”

Aleks Rajkovic M.D., Ph.D., Chief Genomics Officer (CGO), UCSF Health. PMWC 2020 Track 3
Diagnostics in Clinical Practice Chair
“Delivery of clinical genetic testing services, although not profitable, is critical across the spectrum of specialties since almost all specialties are now using genetic testing and ideally require local genetic expertise.”

“Adding sex and gender to today’s studies not only benefits women’s health, it is also key to improving men’s health.”

Chris Cournoyer, former CEO of N-of-One, now strategic advisor to QIAGEN. PMWC 2020 Track 4 ‘Molecular Profiling – From Research to Clinic Chair
“RWD (Real World Data) sets are a critical component in creating a learning system that allows us to modify and improve treatment strategies based on RWE (Real World Evidence).”

Michael Snyder, Ph.D., Professor & Chair, Stanford Center of Genomics & Personalized Medicine. PMWC 2020’s Track 5 Health Data Chair
“…the entire health care system seems totally broken. Nobody pays to keep people healthy, rather the current philosophy is only to pay to fix them, and we have to change that. We need to transform healthcare at all levels–patient, physician, insurance, and regulatory.”

Mary Relling, PharmD, St. Jude Children’s Research Hospital. PMWC 2020 Precision Pharmacotherapy Track Chair
“Preemptive pharmacogenomics testing versus reactive genotyping is cheaper and ensures results will be available at time of prescribing decisions.”

Philip Greenberg, PhD, Fred Hutch Cancer Center, PMWC Luminary Awardee
“Targeted therapies are changing the face of cancer care, and increasingly cancer treatments are becoming patient specific rather than disease specific. Cancer therapy is now an exciting and rapidly evolving field, which holds great promise for both improved efficacy and reduced toxicity.”

Thomas Hawes, Blue Cross Blue Shield Venture Partners. PMWC 2020 Session Chair
“Given that the cost to develop new technology continues to decrease, the appetite for new and better ways to care for people is increasing, and the amount of capital available for healthcare entrepreneurs is at an all-time high. There has never been a better time to be an entrepreneur than now.”

Peter Ganz M.D., Chief of Cardiology, Zuckerberg San Francisco General Hospital, Maurice Eliaser Distinguished Professor of Medicine, UCSF. PMWC 2020 CVD Track Chair
“The health care community will need to focus on thoughtful implementation of new diagnostic modalities. As much of cardiovascular care and reimbursement is now based on practice guidelines, convincing data will need to be accumulated to qualify novel tests and treatments into guidelines.”

Let’s push forward as a community to achieve the common goal of accelerated precision medicine implementation. Any step forward, big or small, will ultimately contribute to the progress of clinical adoption. Here is a sample of those participating at PMWC Jan. 21-24:

UCSF Bakar Computational Health Sci. Inst.; SVB Leerink; Caris Life Sciences
Civilization Ventures; MD Anderson; Foundation Medicine
Cancer Treatment Centers Of America; Funxion; University Of Gothenburg
Mayo Clinic Rochester; SCGPM – Stanford University; ArsenalBio
Michigan State University; Gentueri Inc.; Data4Cure
Bluestar Genomics; Memity.ai; Ardigen
Clarify Health Solutions; Institut Pasteur – Paris; Meta Health Ventures
Swedish Cancer Institute; QB3/UC Berkeley; Boundless Bio Inc.
Google Inc; Quaintise; Assurance Health Data Inc.
Midwestern University; Samsung Research America; Sangamo Therapeutics
DeVine Health Care Connections; Bexion Pharmaceuticals; Illumina
Samsung; Ancestry.com; Verb Surgical
NCI; EvinceMed Corp.; Gladstone Institutes
Baylor University Medical Center; Canvas Ventures; IDbyDNA
Renown Health; IndivuMed; Lam Research
Protean BioDiagnostics; STAT; Protocol Intelligence Inc.
Elsevier; Hc1; OX2 Therapeutics
Inivata; Invitae; QIAGEN
EXXclaim Capital; UCSF; Q Squared | EA Genomics
American Cancer Society; NVIDIA; Allscripts
C2I-Genomics; ZONTAL Inc.; FamHis, Inc.
Roche Diagnostics; Gryphon Bio, Inc.; FDA
Medidata; Agendia; Stanford Center Of Genomics & PM
Indivumed Group; Cleveland Clinic; Aurora Research Institute
Repositive; IQVIA; Health Equity Ventures
BISC GLOBAL Inc; Diadem Biotherapeutics; Psomagen, Inc.
QUANTIOME; SBIR/NCI/NIH; U.S. Bancorp
Wake Forest University; Vickers Venture Partners; Emerald Clinics
Bowhead Health; Cardiologs; Consultant
Caspr Biotech; Engine Biosciences; ProterixBio, Inc
ThedaCare; Anthem; Intelliseq
Everlywell; A*STAR (Agency For Sci., Tech., & Research); Oncohost Ltd.
Ionis Pharmaceuticals; Clinical Expo; Ardigen SA
FACS (American College Of Surgeons); CureMatch; Presagen
GE Healthcare; Taiwan Joint Commission Of PM; City Of Hope Comprehensive Cancer Center
FreMon Scientific; Sunchon Nat. Univ.; Wells Fargo Bank
Active Motif; GigaGen; Genospace
MolDX/ Palmetto GBA; Norgen Biotek Corp.; Karius DX
Seven Bridges; The Latino Cancer Institute; Catalysis Foundation For Health
Q.bio; UC Berkeley; DeciBio Consulting
Tempus, Inc.; Genomelink (AWAKENS); XCures
PwC LLP; Angular Medicine; Centene Corporation
Genomica Medica; Tag.bio; Myriad Neuroscience
Guardant Health; Ambry Genetics; UC San Diego Health
University Of Michigan; Doheny Eye Institute; BioQuick News
Andreessen Horowitz; Convergent Genomics; Indiana University Health
QB3; Sunquest Information Systems; ASAN Med. Ctr. / Health Innov. Big Data Ctr.
Glioblastoma Foundation; Eisai Inc.; Gimpo Hangil Eye Hospital
RTW Investments, LP; Gilead Sciences; Immucor
Hired Brains Research LLC; Obvious Venture; AbbVie
Blackstone Life Sciences; Gnosis Data Analysis; Bio-Me
Xcell Biosciences; CareDx; RAINBOW BIOSCIENCE, LLC
Illumina Ventures; Sanofi Pasteur; Drawbridge Health, Inc.
SNOMED International; Barcelona Supercomputing Center (BSC-CNS); Draw Bridge
NeuScience; Avail Bio; SenseBrain Technology
Weill Cornell Medicine; GeneCentric Therapeutics; University Of Newcastle
Metagenics; Siolta Therapeutics; Si02 Medical Sciences
ZOGENIX Inc; Carmentix; Theracues Innovations Pvt. Ltd.
PicnicHealth; Tel Aviv University; Schatz Reimbursement Strategies LLC
Becton Dickinson; Immunai; Health Management
University Of Washington; ClamClick Inc.; Little Zebra Fund
Samsara BioCapital; Prime Genomics; GRETCHEN M VELASCO, MD PA
Neuron23, Inc.; Stanford Peds Hem Onc/POETIC; Agilent Technologies
BeanStock Ventures; OncoHost; UCLA Technology Development Group
TriHealth; Granite Valuations LLC; TAMC-Curesponse
University Of Pittsburgh And UPMC; Biognosys AG; The University Of Chicago
DNAFeed; Connect Care Health Services; Harvard Medical School
Egg Whisperer; Charité – University Medicine Berlin; Nil
Slalom; Sherlock Biosciences; UC Davis
Helix; MyOme; Qatar Genome
SJF Ventures; Project 10k; Alpha Genomix
CloudMedx; Rosetta Investments, LTD; The Coalition For 21st Century
UCSF Helen Diller Family CCC; Orit Atzmon, PhD; Biovital Health
Janssen R&D; Varian Medical Systems; PreAnalytiX
AB BIOINNOVATIONS, Inc; LifeOmic; Dotlab
Delfi Diagnostics; Eisai; Chan Zuckerberg Initiative
Khosla Ventures; BlueeBee; Guided Clarity
Cellecta Inc.; UNIVERSITY OF PENNSYLVANIA; Breakout Labs
Olivia Newton-John Cancer Research Institute; BioEclipse Therapeutics, Inc; Serametrix Corporation
L.E.K. Consulting; JCVI; Stanford Medicine
R&D Concierge Co.; Variantyx Inc; Humanitics
Evotec; MD Anderson Cancer Center; JSR Life Sciences/JSR Micro, Inc.
Phosphorous; Montefiore Medical Center; Sony Semiconductor Solutions Corporation
Arxeon; Life Science Angels; Pristine Wellness Center
IDT; The Doctor Weighs In; The Second Opinion
Veracyte; Ultivue; Decipher Biosciences
Johns Hopkins School Of Medicine; COMBiNATi; LIH PAO LIFE SCIENCE, CO., LTD.
Broad Institute; Locus Bioscience; Geisinger
Color Genomics; Second Genome; UT MD Anderson Cancer Center
BlueBee; Pfizer; AZothBio Inc.
Stanford Cancer Institute; Gero; Complete Genomics
Frameshift; Immune-Onc Therapeutics, Inc.; Axbio Inc
GenomOncology; Quantumleap Healthcare Collaborative; OVO
Vir Biotechnology; UCSF Center For Community Engagement; Ilgen Bio
CQuentia; San Jose State University; Trans. Pulmonary Immunology Research Center
NanoString Technologies, Inc.; University Of Massachusetts Amherst; MEDNAX Innovation Center
AiVF; Tower World; Camp4 Therapeutics
KRMC; Caribou Biosciences; Biological Dynamics, Inc
Gamoz, Inc.; The Global Alliance For Genomics And Health; Institute Of Cancer Research, UK
AMPEL BioSolutions; Investor And Entrepreneur; Believe Big
UCL Institute Of Neurology; New York Genome Center; Assembly Biosciences
University Of Pittsburgh; Northshore University Health System; CHILDREN’S HOSPITAL OF LOS ANGELES
UCSF BSAC; USCF; GSK Oncology
Ligandal; Fluxus Inc.; True Platform
Battelle; Semaphore Solutions; Yonsei University
Health Intersection, LLC; Epic; SERI
Sarah Cannon; Fred Hutchinson Cancer Research Center; Precision NanoSystems
CausaliT LLC; NanoDimension; Myriad Women’s Health
Capio Biosciences; Arcline Investment Management; Morrison & Foerster LLP
AG Medical Imaging Ltd; JSR Life Sciences; Henry Ford Health System
University Of Colorado Denver; Biovica; Phenomics Health Inc.
Santa Cruz Integration; American Red Cross; Duke University Health System
Revital Therapeutics; Duke University; UCSC
PT Prodia Widyahusada Tbk; Stanford School Of Medicine; Morehouse School Of Medicine
Univfy; Memorial University; Fred Hutch Cancer Research Center
Univercity Of Central Florida; BryoLogyx Inc; Cisco
SEQSTER; Baebies, Inc.; Innovation Policy Solutions
West Cancer Center; ASCO; Integral Health
Phosphorus; Lyell Immunopharma; Yale
Goldbug Strategies; RS Bioventures; Institute For Systems Biology
Stanford University School Of Medicine; Hologic; Sutter Health
Molecular Stethoscope; Cardea; The Jackson Laboratory
KP; Genapsys; Cobo Technologies
MedCity News; Lynx.MD; Frontier Diagnostics, LLC
IndieBio/SOSV; Ancestry; Bluestar Genomics, Inc.
C2I Genomics; Novartis; DCVC
Molecular Health GmbH; MiR Scientific; Intervention Insights
Medcan; CTCA; InformedDNA
UCSF Foundation Investment Company; Amgen Inc.; Ariel Precision Medicine
Stanford Bio-X @ Stanford University; Felix Biotechnology; NIH/VRC
Jupiter; Mount Sinai Health System; University Of Central Florida
Stanford/POETIC; GNS Healthcare; Medabome Research Institute
BioPath Ventures; AliveAndKickn; Cure SMA
VIlnius University; Sanford Imagenetics; Agilent Technolgoies
U. Of Pennsylvania Perelman School Of Med.; Dettloff Engineering; Seoul St. Mary’s Hospital
Nucleai; Pulse Infoframe; Sheppard Mullin
The CENTER; Triple Ring Tech; Curegenix, Inc.
UCSF-School Of Pharmacy; Recursion Pharmaceuticals; Kryptos Biotechnologies
Public Health Institute; Minerva Biotechnologies; NKarta Therapeutics
Omics Data Automation; Xooa; Bionano Genomics
Key Tech; R&D Ribitzky; Seres Therapeutics
Celldom, Inc.; San Francisco Business Times; Streck, Inc.
Exact Sciences; ANGLE; Quantgene
UC Santa Cruz Genomics Institute; The University Of York; Philips
University Of Colorado; K Health; Translational Sciences
UCSC Genomics Institute; Glooko; Kaiser Permanente
Yourgene Health; AgeX Therapeutics, Inc.; Personal Genome Diagnostics
Siemens Healthineers; LGC Clinical Diag SeraCare; S2 Genomics
Refuge Biotechnologies; Scribe Biosciences, Inc.; JR Biotech Solutions LLC
Merus; Stilla Technologies; Viome
Novome Biotechnologies; Oncocyte; AACR
Deallus Consulting Ltd; King Faisal U./College Of Clinical Pharmacy; Cofactor Genomics
Intersect Diagnostics; College Of Clinical Pharmacy/King Faisal University; Nashville Biosciences
Sunquest; Dartmouth; BioSyntagma
Genomic Health Inc.; Vikor Scientific; Inflammatix
Intermountain Precision Genomics; Aga Khan University, Karachi; Microsoft Healthcare
GO2; NRS; QIAGEN Digital Insights
Contextual Genomics Inc.; Triple Ring Technologies; MIT
Bayer; Agilent Technologies, Inc.; AsiaBiome
Medial EarlySign; Nanostring; Starr Consulting
Synthego; Buffalo Niagara Medical Campus, Inc; Molecular Decisions
Genomenon; Tempus; Chrysalis Biomedical Advisors
Evidation Health, Inc.; Applied BioMath; Metagenics -Personalized Lifestyle Med. Ctr.
Providence Cancer Center; Pfizer, Inc.; Carlino Consulting
5AM Ventures; Sangamo; 10x Genomics
Profound Ventures; Marshfield Clinic Research Institute; TwinStrand Biosciences
Twist Bioscience; Dell Technologies; Aetna
MedAnswers, Inc; The Univ Of Iowa; PEEL Therapeutics
Kleiner Perkins; University Of Calgary; Bloomberg Law
Bruce Quinn Associates LLC; HUSKY PHOTONICS; Memorial Sloan Kettering Cancer Center
DiscernDx; The U. Of Texas M.D. Anderson Cancer Center; Angel Investor
Columbia University; Phi Life Sciences; York University
The Christ Hospital Health Network; 2bPrecise; Mila’s Miracle Foundation
Immunomedics; Vision Critical; CA Governor’s Office Of Planning & Research
Medcurio, Inc; National Inst. Of Standards And Tech. (NIST); Canaan
UC San Diego; Synlogic Therapeutics; University Of Florida
HeartFlow; Gilead; US BANK
Paige.AI; BioFire Diagnostics; AstraZeneca
Paige; BD; Serotiny
CareLoop; Janssen Pharma Company Of Johnson & Johnson; NASW
InterVenn Biosciences; IsoPlexis; LaunchWorks
OraSure/DNAGenotek; DGMIF/New Drug Development Center; ISB
Takara Bio USA; Snyder Lab At Stanford Medicine; Johnson & Johnson Innovation, JLABS
C P Consulting; Massive Bio; VastBiome
Caprion; First Moscow State Medical U; J. Craig Venter Institute
Popper And Company; NAVAN; BioCentury Inc.
J&J INNOVATION; Dalton Bioanalytics; Celmatix
Sanford Health; University Of Wisconsin-Madison; KVB Consulting
Zero Breast Cancer; Mindscale; Second Genome Inc.
Leidos; WuXi NextCode; Viracor-Eurofins
IGENOMIX; Navigate BioPharma (A Novartis Subsidiary); CosmosID
Genoprimer; Abbvie (PCYC); Nodexus
Dhan AI Inc.; Intermountain Healthcare; Apple
NHIMC Ilsan Hospital; Institute For Computational Health Sciences; Deloitte Consulting LLP
CEO; NeoGenomics Laboratories; Central New York Biotech Accelerator
Regeneron Pharmaceuticals; Genetic Alliance; Alain Pinel Realtors
Stanford Peds Hem Onc; Honoree Guest; Arizona State University
Mission Bio; Regenstrief Institute/ IU School Of Medicine; Blueprint Medicines
University Of Texas At Austin; Genomind; PierianDx
Genelex Solutions LLC; Centene; OncoTracker, Inc
Multiple Myeloma Research Foundation; Personalized Medicine Care Dx (PMCDx); Syapse
Amplion; Varian; Claret Biosciences
All Of Us Research Program; University Of The Pacific; Freelance
SageMedic Corp; Dosis Inc.; Adecco @ Google
ASU; NemaMetrix; Oregon Health And Science University
Clinical OMICs; Google Cloud; Double Helix LLC
Johnson & Johnson; University College London / Leiden University; De Anza College
Imagia; Beth Israel Deaconess Medical Center; Khalifa Inst. For Personalized Cancer Therapy
UCSD, Moores Cancer Center; SJV Inc; UCSF Catalyst Program
DrugBank; Deep Lens; Decisive Biomedicine
Bosch; Captis Diagnostics; GenomeSmart
Omics Data Automation Inc; Intralink Group; MBP/University Of California, Davis
Spectrum Health; BioDiscovery; Tmunity Therapeutics, Inc
Metabolon; Azothbio; UC Santa Cruz
Medmesafe; 100 Plus Capital; Stanford Metabolic Health Center
Future Family, Inc.; Decision Resources Group; Quanterix Corporation
UCLA Institute For Precision Health; Tenaya Therapeutics; RubrYc Therapeutics
Q Bio; Aurora Bio; BenevolentAI
Portalyze Point Of Care LTD; ATUM; BIOAGE
Travera; UCSD; Nanosens
Notable Labs; Supra Oncology; S F State University
Pendulum Therapeutics; Ciitizen; UCLA
SOPHiA GENETICS; BioWorld MedTech; HAP/Henry Ford Health System
Huntsman Cancer Institute At The U. Of Utah; 5 Prime Life Science Consulting, Inc.; PreSciDx LLC
Nference; Personalis; CHIMERA BIOENGINEERING
UC Health; Microsoft; NMDP
Dignity Health; Sanofi Genzyme; YouScript, Inc.
Clinical Innovation Partners LLC; SomaLogic; NIH
GRAIL; SomicsMed; 4basecare Genomics Private Limited
JPM, MDPI; AdventHealth; MD Precisionhealth
University Of San Diego; Genomic Health; YUHAN CORP.
DataSpeaks, Inc.; Stem Pharm; CA Pacific Medical Center Research Institute
Nanotein Technology; Sema4; Psomagen
WM Family Trust; Coral Genomics; Verana Health
Loxo Oncology; Curebase; Huma.AI
WAPG; Prothea-X Ltd; Persona Biome, Inc.
Sio2 Medical Sciences; Icahn School Of Med. At Mount Sinai; Sema4; Colgate Palmolive
CoreBiome; Physiosigns Inc; Geneticist, Fejerman Labs
Hughes Management Group; Datavant; Merck
University Of Chicago; John Hopkins; BloodPAC
CCS Associates; OX2 Therapeutics.; 4Paws Dx, Inc.
Levine Media Group; Cimplrx Inc.; Medicines360
LEO Innovation Lab (LEO Pharma); ImpriMed, Inc.; UCSF/UCB
Invivoscribe, Inc.; University Of North Carolina At Chapel Hill; SiO2 Materials Science
US Pharmacopeia; Enable Medicine; Sirius Computer Solutions
Diversigen, Inc; AAMC; Lee N Newcomer Consulting
Oxford Nanopore Technologies Ltd; UCSF Health; Jounce Therapeutics
Ibex Medical Analytics; Savor Health; Cellecta
S. F. State University; The Jackson Lab For Genomic Med.; Stanford
BioMedVerse; State U. Of NY At Binghamton; American Heart Association; Ohio State University
Apixio; Tempus Inc.; Highmark BlueCross/BlueShield
Kailos Genetics; Genentech; Nektar Therapeutics
Thrive; Ramakanth, H.C. Wainwright; NCI/NIH
SUNY Upstate Medical University; Tokai University School Of Medicine; Biotech Startups
San Diego Blood Bank; Hitachi High Technologies; Angarus Therapeutics
DeepThink Health; Kyoto University; DNA Genotek
Apostle Inc; Wamberg Genomic Advisors; UC San Francisco
AveXis; University Of Virginia Health System; Genome Medical
ProSci Inc.; Paragon Genomics; Genomics Institute UCSC
UC Davis Comprehensive Cancer Center; Slone Partners; Janssen
Ontera; MeMed Dx; Biomatrica
Astounding HealthTech; UPMC; TB-Seq Inc.
Human Longevity; Lexent Bio; Massachusetts Institute Of Technology
Providence Health & Services; DesignWorlds For College & Careers; Onconetics Pharmaceuticals, Inc.
Quest Diagnostics; Mayo Clinic – Center For Individualized Med.; ChromaCode Inc.
UCLA Health/Geffen School Of Medicine; Wiley Systems, Inc.; TrineOmics, Inc.
Freenome; Mission Hospital; Duke University Medical Center
LunaDNA; UNC School Of Medicine; Verseon
LabCorp; InVivo AI; Dategra
Thermo Fisher Scientific; Parker Institute For Cancer Immunotherapy; Microbiome Insights
Global Impact NRS Health And Wellness; Aiforia; Apton Biosystems
University Of Vermont; BryoLogyx Inc.; Agilon Health
Verily Life Sciences; Teal Lion LLC; Vytautas Magnus University
ONEHEALTH PARTNERS; Intomics; Strand Life Sciences
Seventure; Adaptive Biotechnologies; MyoKardia
United Therapeutics; Menlo Ventures; DNAstack
Beigene; M2Gen; Admera Health
Prodia Clinical Laboratory; Sunquest Information Systems; Illumina Accelerator
BloodQ; Enlightenbio LLC; 712 North
DeClarity; Genialis, Inc; Genedata
Colgate Palmolive Co/BioSolutions; Synapsis Search Recruiting; Flatiron Health
Putnam Associates; Moffitt Cancer Center; Uphold
Translational Software; Indiana University; Cedars-Sinai Medical Center
UCLA Health; Ambry Gen. & Invicro, Konica Minolta Comp.; Boehringer Ingelheim
Santa Clara University School Of Law; Vir Predictive Medicine; Big4Bio
Genomics Consulting; SEngine Precision Medicine; UTHealth SBMI
Halloran Consulting Group; Deepcell; Exosome Diagnostics
MBC BioLabs; Addario Lung Cancer Medical Institute; Quanterix
Sengenics Corporation Pte Ltd; SpectrumDNA; Google
Frameshift Genomics; Oncorus Inc.; Crystal Genetics, Inc.
University Of Oxford; Blackhawk Genomics; MatriSys Bioscience, Inc.
Texas Oncology; Baylor College Of Medicine; PerkinElmer Genomics
Levine Cancer Institute, Atrium Health; Tizona Therapeutics, Inc.; AKESOgen
Bristol-Myers Squibb; The MediSearch Institute; Immunis.AI
University Of Delaware; Agilent; UCSF Innovation Ventures
Infocom America, Inc.; Bio-Rad; The BioCollective
Emedgene; GenomeWeb/Precision Oncology News; Tempus Labs
CytoReason; Medable; Molecular Devices
Case Western; Mammoth Biosciences; UCSD Health Sciences/Precisione Clinic
E P Systems; Eidos Therapeutics; Quantum Insights, Inc.
Bio-Rad Laboratories; Janssen Pharmaceutical; Providence
Biostrap; R-Pharm; St. Jude Children’s Research Hospital
Scientific Commercialization, LLC; The Center For Connected Medicine, UPMC; Axial Therapeutics
Dana-Farber Cancer Institute; IBM; Innovenn, Inc.
Vanderbilt University; Natera; Innovate For Health
BioMedical Insights, Inc.; Johns Hopkins University; JW Theriac Pharmaceutical
Health Catalyst; L7 Informatics; Aluna Health
My Gene Counsel; Tabula Rasa Healthcare; Cerner Corporation
MBL International; University Of Michigan College Of Pharmacy; OncoTracker
Hamad Medical Corporation; Kite Pharma; Deerfield
LabPulse; Oncobox; Merchant Adventure Investment Advisors, LLC
Deallus; Mosaic; UPMC Enterprises
BlueCross BlueShield Venture Partners; BioChain Institute, Inc.; Amazon
Naked Biome; HL7 Da Vinci Project; Endpoint Health
SJSU; Gritstone Oncology; Life Sciences Solutions
Cancer Commons; Deep Valley Labs; CTCA Health
Case Western Reserve University; Foresite Capital Management; Bioceryx Technologies Inc
Palantir; A.C.Camargo Cancer Center; Stanford Health Care
LeapAnalysis; GV; Droice Labs
Poseida Therapeutics; Novome; Hyman, Phelps & McNamara
Wavemaker 360 Health; IU Health; Aldevron
MolecularMatch, Inc.; Schatz Reimbursement Strategies; U. Of Colorado Anschutz Medical Campus
ND Capital; Janssen Oncology; FAA/Civil Aerospace Medical Institute
Personalized Science, LLC; Medidata Solutions; Parker Inst. For Cancer Immunotherapy
23andMe; Doc.ai; John Muir Health
Roche; Intellectual Venture; McDermott Will & Emery
DayTwo; Wake Forest Baptist Comprehensive Cancer Ctr.; Leukemia & Lymphoma Society
National Cancer Institute; National Science Foundation; St. Catherine University
Roche Molecular; Stanford Genome Technology Center; Multiomic Advisory Services
BCHSI At UCSF; Celltomics; Vanedge Capital
Gladstone; St. Jude; U Of Tennessee Health Science Ctr.; SynderBio, Inc
Roche Sequencing Solutions; Beverly Hills Institute For Precision Med.; North Carolina Biotechnology Center
Genesis Therapeutics; Octave BioSciences; Google Health

Contact [email protected] if you are interested in attending, but your employer does not cover attendance. Together we may be able to find a solution that makes your attendance possible.

Looking forward to seeing you next week at PMWC 2020, the leading global precision medicine conference.